Global News Feed
Home
Bookmarks
Preferences
World
Extract
Custom
Fetch
Install
Total
Unread
Saved
More
Preferences
Custom News
Fetch News
Install App
Home
Saved
World
Extract
More
Prev
Back to News
Next
EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say
โ
Source:
Reuters
Category:
General
Region:
China
Published:
September 18, 2026 at 16:54
๐ Summary
EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say Reuters
๐ Read Full Article at Reuters
โจ Extract Article
๐ค Share
๐ท๏ธ Keywords:
exclusive
weighs
allowing
most
pharma
licensing
deals
china
sources
๐ฌ Social Media Posts
๐ Refetch Posts
Searching social media for related posts...
Click "Fetch Related Posts" to find social media discussions about this article
๐ฐ Related Articles
Hengrui Pharma reports 88.9% rise in 2026 third-quarter profit on licensing deals
Reuters
ยท
Oct 27
EXCLUSIVE: US weighs polysilicon price floor, tariffs to counter China in solar and chips
Reuters
ยท
Aug 04
China weighs allowing ByteDance, Alibaba to buy new Nvidia chips, The Information reports
Reuters
ยท
Sep 27
EXCLUSIVE: White House weighs how to use Defense Production Act to expand US oil refining capacity, sources say
Reuters
ยท
Sep 11
Previous Article
Next Article